Atlas Trials

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Clinical trial NCT03128463 · UNKNOWN

Trial details

NCT number
NCT03128463
Sponsor
Xun Xu
Status
UNKNOWN
Study type
OBSERVATIONAL
Age-Related Macular DegenerationPolypoidal Choroidal VasculopathyPathological MyopiaConberceptPharmacogenomic
Start date
2017-02-28
Primary completion
2018-12-31
Enrollment
5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.